Société Française de Toxicologie
Menu icoMenu232White icoCross32White

Ajoutez un logo, un bouton, des réseaux sociaux

Cliquez pour éditer
  • Société Française de Toxicologie
  • Actualités ▴▾
    • Actualités 2025
    • Actualités 2024
    • Actualités 2023
  • La SFT ▴▾
    • Notre histoire
    • Les statuts
    • Les membres du Bureau
  • Adhérer et cotiser ▴▾
    • Adhérer à la SFT
    • Cotiser à la SFT
  • Le congrès 2025 ▴▾
    • Sponsors
    • Le programme
    • Inscriptions
    • Posters
    • Où et quand ?
    • Photos
  • Les webinaires de la SFT ▴▾
    • 2025
    • 2024
    • 2022
    • 2021
  • Autres événements ▴▾
    • 2025
    • 2026
  • Registre Européen des toxicologues (ERT) ▴▾
    • Généralités
    • 1ère demande d'inscription
    • Renouvellement d'inscription
  • Jeunes toxicologues ▴▾
    • Bourses de congrès
    • Prix de thèse
    • CFJTox
  • Cours et formation continue ▴▾
  • Offres d'emploi ▴▾
  • Archives des congrès de la SFT ▴▾
    • 2024
    • 2023
    • 2022
    • 2021
    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
    • Et avant...
  • Se connecter
  • Actualités 2025
  • Actualités 2024
  • Actualités 2023
  • Notre histoire
  • Les statuts
  • Les membres du Bureau
  • Adhérer à la SFT
  • Cotiser à la SFT
  • Sponsors
  • Le programme
  • Inscriptions
  • Posters
  • Où et quand ?
  • Photos
  • 2025
  • 2024
  • 2022
  • 2021
  • 2025
  • 2026
  • Généralités
  • 1ère demande d'inscription
  • Renouvellement d'inscription
  • Bourses de congrès
  • Prix de thèse
  • CFJTox
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • Et avant...
Retour

Micro-sampling in Toxicology studies

Micro-sampling in Toxicology Studies: Enhancing 3Rs While Maintaining Scientific Integrity

Lionel Hurst¹, Klaus Biemel¹, Corinne Guicheney²*

¹Pharmacelsus, Saarbrücken, Germany

²GBA Pharma, Plobsheim, France

Micro-sampling, defined as the collection of blood volumes ≤50 µL, is increasingly recognized as a valuable approach in toxicology studies. Conventional toxicokinetic (TK) designs often rely on satellite animals and large-volume sampling, contributing significantly to animal use and distress. Micro-sampling offers a practical solution aligned with the principles of Replacement, Refinement, and Reduction (3Rs), enabling exposure-response assessments in main study animals while reducing overall animal numbers and improving welfare.

This poster reviews the implementation of micro-sampling in rodent safety studies, highlighting technical, analytical, and regulatory considerations. Key challenges include ensuring bioanalytical sensitivity, managing limited sample volumes for ancillary analyses (e.g., ISR, metabolite characterization), and mitigating potential impacts on toxicological endpoints. Strategies such as sample dilution, use of highly sensitive instrumentation, and adoption of sparse sampling combined with population pharmacokinetic modelling have proven effective.

Operational success depends on robust training, validated procedures, and appropriate sampling devices (e.g., capillary tubes, Minivettes®). Regulatory guidance supports micro-sampling, provided bioanalytical methods are validated and species-specific factors are considered. Evidence indicates that micro-sampling can be performed without adverse toxicological consequences, even in repeated sampling scenarios.

In conclusion, micro-sampling represents a scientifically sound and ethically responsible approach for TK assessments in toxicology studies. Its adoption can significantly reduce animal use and distress without compromising data integrity, supporting industry commitments to the 3Rs.

Keywords: micro-sampling, toxicokinetics, 3Rs, rodent studies

icoLinkedin35Color icoComment35Color
icoLinkedin35Color icoComment35Color
0 commentaire(s)
ou
Connectez-vous
Aucun commentaire pour le moment.
Consultez également
Container closure system of a drug-device combination product

Container closure system of a drug-device combination product

Biological evaluation and management of changes for a container closure system of a drug-device...

23 novembre 2025
iVEMPS: QSAR Predicting Thyroid Receptor Disruption

iVEMPS: QSAR Predicting Thyroid Receptor Disruption

iVEMPS: A High-Accuracy QSAR Predicting Thyroid Receptor Disruption as a First Step Toward...

23 novembre 2025
COSMETICK digital tool

COSMETICK digital tool

Analysis of the toxicological profiles of cosmetic ingredients and risks for cosmetic product:...

23 novembre 2025
Effects of hepatic enzyme inducers on NIS, TPO and DIO1-2-3 activities

Effects of hepatic enzyme inducers on NIS, TPO and DIO1-2-3 activities

Effects of hepatic enzyme inducers on in vitro NIS, TPO, and DIO1-2-3 activitiesAudrey Baze1,...

23 novembre 2025
Characterization of representative plasticizer exposures in NICU neonates

Characterization of representative plasticizer exposures in NICU neonates

Characterization of representative plasticizer exposures in NICU neonates using non-negative...

23 novembre 2025
NAMs for evaluating DART potential

NAMs for evaluating DART potential

New approach methodologies for evaluating DART potential: Review on state of the art,...

23 novembre 2025
Hôpital Fernand-Widal - 200 rue du faubourg Saint-Denis - 75475 Paris Cedex 10 / Contact : sft.secretariat@gmail.com
icoLinkedin24Color
  • Plan du site
  • Licences
  • Mentions légales
  • CGUV
  • Paramétrer les cookies
  • Se connecter
  • Propulsé par AssoConnect, le logiciel des associations Professionnelles